key: cord-0907836-gywue1g9
authors: Malenfant, Jason H; Eslami, Michelle; Dao, Bonnie L; Moore, Leo; Green, Nicole; Silver, David; OYong, Kelsey; Ruparelia, Ashutosh; Fisher, Rebecca; Wood, Julia S; Faisal, Mohammad; Washburn, Faith; Shvartsblat, Steve; Jewell, Mirna P; Romo, Tiffany; Foo, Chelsea; Salazar, Angela; Rajagopalan, Shobita; Rubin, Zachary A; Gounder, Prabhu
title: Seroprevalence of SARS-CoV-2 Among Skilled Nursing Facility Residents and Staff Members — Los Angeles County, August–September 2020
date: 2021-05-24
journal: J Infect Dis
DOI: 10.1093/infdis/jiab281
sha: 2df2b9d6cbdffe70f8d97356389d992aa1f21cdc
doc_id: 907836
cord_uid: gywue1g9

BACKGROUND: The prevalence of current/past coronavirus disease 2019 (COVID-19) in skilled nursing facility (SNF) residents is unknown because of asymptomatic infection and constrained testing capacity early in the pandemic. We conducted a seroprevalence survey (SPS) to determine a more comprehensive prevalence of past COVID-19 in Los Angeles County SNF residents and staff members. METHODS: We recruited participants from 24 facilities; participants were requested to submit a nasopharyngeal (NP) swab for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) PCR testing and serum for detection of SARS-CoV-2 antibodies. All participants were cross-referenced with our surveillance database to identify persons with prior positive SARS-CoV-2 results. RESULTS: From August 18 to September 24, 2020, we enrolled 3,305 participants (1,340 residents and 1,965 staff members). Among 856 residents providing serum, 362 (42%) had current/past SARS-CoV-2 infection. Of the 346 serology positive residents, 199 (58%) did not have a documented prior positive SARS-CoV-2 PCR result. Among 1,806 staff members providing serum, 454 (25%) had current/past SARS-CoV-2 infection. Of the 447 serology positive staff members, 353 (79%) did not have a documented prior positive SARS-CoV-2 PCR result. CONCLUSIONS: Past testing practices and policies missed a substantial number of SARS-CoV-2 infections in SNF residents and staff members.

As of January 19, 2021, over 24.2 million cases of coronavirus disease 2019 have been reported in the United States, including approximately 401,000 deaths [1] .

Although less than 1% of the U.S. population resides in long-term care facilities, 40% of COVID-19-associated deaths have occurred among long-term care facility residents [2] . In The reasons for the decline in the number and size of COVID-19 outbreaks in nursing homes are likely multifactorial. Recognition of the role of asymptomatic transmission led to the implementation of universal masking policies in nursing homes [3, 4, 5] . Introduction and transmission of SARS-CoV-2 in nursing homes was further reduced through improved infection control procedures, such as isolating SARS-CoV-2 infected residents in physically separated -red-zones‖ and placing newly admitted residents in quarantine. Regulations A c c e p t e d M a n u s c r i p t 6 requiring weekly surveillance testing for SARS-CoV-2 in nursing home staff and residents potentially resulted in earlier detection and containment of COVID-19 outbreaks [6] . It is unknown how much of the decline in COVID-19 cases and outbreaks in nursing homes is attributable to immunity among staff and residents who had recovered from infection acquired during prior outbreaks at their facilities.

Early in the pandemic, SARS-CoV-2 testing was available only through the DPH Public Health Laboratory (PHL). Before the recognition of asymptomatic transmission, SARS-CoV-2 testing was only offered for the first person in a nursing home who developed symptoms; other residents and staff subsequently experiencing respiratory symptoms in the facility were presumed to have COVID-19 and isolated accordingly. Even after commercial SARS-CoV-2 tests became available in late March and April, many nursing homes did not have timely access to testing because community demand exceeded the available testing capacity. Therefore, it is likely that many nursing home residents and staff had undiagnosed COVID-19. We aimed to conduct a seroprevalence survey to obtain a more comprehensive estimate of the prevalence of exposure to SARS-CoV-2 among residents and staff in Los Angeles

A c c e p t e d M a n u s c r i p t 7

The LAC DPH conducts surveillance for approximately 10 million residents in 86 cities excluding Long Beach and Pasadena, which have independent health departments. Healthcare providers in LAC are mandated to report to DPH all confirmed COVID-19 cases and clinical laboratories are mandated to report all SARS-CoV-2 diagnostic test results (positive, negative, indeterminate, and inconclusive). Staff from DPH attempt to interview all persons reported with COVID-19 to identify risk factors, close contacts, and exposure settings with a potential for an outbreak (e.g., nursing home). All outbreaks are assigned to DPH field teams, comprising physicians and nurses, for further investigation and management. All case reports and investigation data are entered into Integrated Reporting Investigation and Surveillance System (IRIS), DPH's central surveillance database.

Since June 2020, DPH has required SNF operators to conduct weekly surveillance testing of 25% of directly employed staff and 10% of residents by using a SARS-CoV-2 polymerase chain reaction (PCR) test. If a staff member or resident is diagnosed with COVID-19, then the SNF is required to conduct outbreak testing of all staff and residents weekly until no new positive test results are detected on two consecutive rounds of testing. Table   1 ). By comparison, the median licensed bed capacity among all 315 SNFs in LAC was 99 beds (Q1-Q3: 62-124). At the end of our study period on September 24, 2020, there were a total of 38,242 licensed bed across all 315 SNFs and 28,315 (74%) beds were occupied (unpublished data from LAC Health Facilities Inspection Division).

From August 18 to September 24, 2020, DPH nursing teams were deployed to obtain from residents and staff at the 24 SNFs nasopharyngeal (NP) swab specimen for SARS-CoV-2 PCR testing and serum for detection of IgG antibodies against SARS-CoV-2. Demographic information on all potential staff and resident participants was collected in advance for preregistration with DPH PHL and printing of laboratory requisition forms. Testing for SARS-CoV-2 by PCR was offered to all staff and residents who had not tested positive within the previous 90 days. Serologic testing was offered to all staff and residents who submitted a NP swab specimen and to persons who were excluded from PCR testing because they had previously tested positive for SARS-CoV-2. Specimen were packed in cold packs and shipped via courier to PHL for processing. Informed verbal consent was obtained from all A c c e p t e d M a n u s c r i p t 9 participants; persons who did not have capacity to provide verbal consent were excluded from participation.

For SARS-CoV-2 testing, PHL utilized the Hologic Panther Fusion SARS-CoV2, Hologic

Panther TMA SARS-COV2, or CDC 2019 nCOV reverse-transcription PCR assays. Serum or plasma samples were used by PHL for serologic testing. All sera were tested by using two distinct automated chemiluminescent immunoassays as part of orthogonal algorithm to improve specificity and positive predictive value: the Abbott SARS-CoV2 assay (conducted on the Abbott i1000SR instrument that tests for IgG antibody against nucleoprotein), and the Diasorin SARS-CoV2 assay (conducted on the Diasorin Liaison XL instrument that tests for IgG antibody against spike protein) [7] . Participants were categorized as seropositive if either test yielded a positive result.

All participants' demographic information and laboratory test results were stored in PHL's laboratory information system, Sunquest Information Systems. To obtain the results of any prior SARS-CoV-2 PCR tests conducted for study participants, we cross-referenced study participants demographic information with IRIS by using a deterministic matching process based on first name, last name, a composite variable composed of the first 3 letters of first and last name, and a name flip along with DOB. To obtain the history of prior COVID-19 outbreaks in each participating SNF, we reviewed the IRIS outbreak investigation reports for each facility to determine the dates of the first and last reported cases, cumulative counts of resident and staff cases, and bed capacity.

A c c e p t e d M a n u s c r i p t

Characteristics of PCR-positive and PCR-negative groups, and seropositive and seronegative groups, were compared using Pearson's chi-squared tests and Fisher's exact test for categorical variables. All statistical analyses were conducted using SAS 9.4 software.

This project was reviewed and approved by the LAC Institutional Review Board (IRB).

From August 18 to September 24, 2020, we enrolled 3,305 participants from 24 SNFs. All Table) . Among the 1,340 resident participants, 704 (53%) provided both NP swab and serum specimen, 484 (36%) provided NP swab alone, and 152 (11%) provided serum specimen alone. Among the 1,965 staff member participants, 1,674 (85%) provided both NP swab and serum specimen, 159 (8%) provided NP swab alone, and 132 (7%) provided serum specimen alone.

Of the 1,188 residents who submitted an NP swab, 608 (51%) were male and the median age was 72 years (Q1-Q3: 63-83 years; Table 1 ). Of the 856 residents who submitted serum for serologic testing, 440 (51%) were male and the median age was 72 years (Q1-Q3: 63-83 years). Of the 1,833 staff members who submitted an NP swab, 533 (29%) were male and the A c c e p t e d M a n u s c r i p t 11 median age was 45 years (Q1-Q3: 32-55 years). Of the 1,806 staff members who submitted serum for serologic testing, 523 (29%) were male and the median age was 45 years (Q1-Q3: 33-55 years). There were no significant differences by sex or age between participants with and without a positive SARS-CoV-2 PCR result and between participants with and without positive SARS-CoV-2 antibodies.

Among the 856 residents who provided serum, 346 (40%) had detectable SARS-CoV-2 antibodies ( Table 2 ). An additional 2 (<1%) serology negative residents had a positive (Table 3) . 

We conducted a seroprevalence survey at 24 LAC SNFs to determine more comprehensively the prevalence of current and past SARS-CoV-2 infection. The majority of resident and staff study participants had COVID-19 that was not detected by past testing policies and practices.

The results indicate that past COVID-19 outbreaks in SNFs were potentially larger than A c c e p t e d M a n u s c r i p t 13 A greater proportion of residents were seropositive for SARS-CoV-2 compared with staff. The exact reasons for why residents appear to be at increased risk for COVID-19 compared with staff are not known. It is likely that staff members benefited from having access to personal protective equipment (PPE) to reduce their risk of infection within SNFs. Although residents are encouraged to wear a face covering at all times, adherence to this recommendation is unclear and non-medical face coverings are not intended to protect against infection. The majority of residents in our study resided in multi-occupancy rooms, which is typical of most nursing facilities in the United States.

Therefore, in addition to their own personal risk for acquiring COVID-19, residents could have the added risk of infection based on their roommate's exposures (e.g., visits from friends and family).

Although all SNFs in LAC now conduct daily symptoms screening for respiratory illness and have physically separated "red zones" to isolate residents with COVID-19, residents still remain at increased risk for infection from a roommate or staff member who might have asymptomatic/undetected COVID-19 [8] .

Our results allow us to estimate the relative risk for having COVID-19 among SNF residents compared with the general LA County population. There have been two assessments of the seroprevalence of SARS-CoV-2 in the LAC general population to date. A community seroprevalence study conducted in April 2020 identified that 35 (4.1%) of 865 participants were seropositive of SARS-CoV-2 [9] . Another study assessed SARS-CoV-2 seropositivity among 790 LAC university students during April 29-May 8, 2020 and demonstrated a seroprevalence of 4.0% [10] . By comparison, SNF residents and staff in our study conducted approximately four months after the community studies were 10-and 6-times more likely, respectively, to have evidence of past SARS-CoV-2 infection. Of note, the seropositivity rate among SNF staff in our study also exceeded the rate reported among healthcare personnel at a large academic medical center in LAC during May 26-June 5, 2020 (approximately 8%) [11] . Another seroprevalence study conducted among hospital and A c c e p t e d M a n u s c r i p t 14 SNF healthcare workers in Rhode Island during July 17-August 28, 2020 identified a seropositivity rate of 3.1% (95% CI 2.7%-3.5%) among hospital personnel and 13.1% (95% CI 11.5%-14.9%) among nursing home personnel; the lower seropositivity rate compared with our study could result from differences in community transmission (i.e., risk for staff exposure) and in the types of healthcare workers who participated in the study (i.e., intensity of direct patient contact) [12] Our study has limitations. First, we enrolled a convenience sample of participants from 24 SNFs, which means our results are likely not representative of all 315 SNFs in LAC. Although our results cannot be generalized to all 315 freestanding SNFs within DPH jurisdiction, the characteristics of residents and the infection control practices at the participating SNFs are typical of other centers in LAC. Second, the concentration of antibodies against SARS-CoV-2 decline over time, so participants whose concentration fell below level of detection would have been misclassified as SARS-CoV-2 unexposed [13] . In our study, 8.7% of residents and 3.1% of staff who had a documented prior positive PCR result were seronegative for SARS-CoV-2. Further, residents who were infected might have left the facility and replaced by new residents who were not exposed to the previous outbreaks in the facility, which would also reduce our ascertainment of the prevalence of past infection at the facility. Finally, our deterministic matching algorithm could have missed prior PCR results if their name did not exactly match what was provided for enrollment in the study and PCR results for persons whose address was outside LA County (the results would have been reported to that jurisdiction).

Our study provides a more comprehensive estimate of the prevalence of exposure to SARS-CoV-2 among SNF residents and staff. These results provide context for assessing the effectiveness of past policies and programs for preventing and controlling COVID-19 in SNFs. Our results can also inform A c c e p t e d M a n u s c r i p t 15 the design of studies to assess the effectiveness of COVID-19 vaccines in preventing infection and outbreaks in SNFs. We demonstrated that a substantial proportion of SNF staff members and residents were potentially unaware of their past infection status. Thus, misclassifying unvaccinated persons with unknown infection as susceptible might reduce the observed effectiveness of the vaccine. Incorporating an orthogonal serologic testing strategy with high test specificity (i.e., >99.5%) to minimize the potential for false positive results could improve classification of persons with evidence of past infection [7] . Although a positive qualitative SARS-CoV-2 antibody test result does not provide a good correlate for protection from subsequent infection, such tests could help investigators understand the potential misclassification of immune status in VE studies [7] .

We demonstrated that past testing practices/policies missed a substantial number of SARS-CoV-2 infections in SNF residents and staff members. Our results could inform vaccine rollout strategies, interpretation of trends in COVID-19 incidence in SNFs by adjusting the denominator for nonsusceptible persons, and the design of potential vaccine effectiveness studies because nonvaccinated persons could be misclassified as susceptible.

A c c e p t e d M a n u s c r i p t M a n u s c r i p t M a n u s c r i p t M a n u s c r i p t 20 A c c e p t e d M a n u s c r i p t 29 Figure 1 

An interactive web-based dashboard to track COVID-19 in real time

The COVID tracking project. The Atlantic Monthly Group

Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility

Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility

Presymptomatic transmission of SARS-CoV-2 amongst residents and staff at a skilled nursing facility: results of real-time PCR and serologic testing

Guidelines for preventing and managing COVID-19 in skilled nursing facilities

Interim guidelines for COVID-19 antibody testing

High proportion of asymptomatic SARS-CoV-2 infections in 9 long-term care facilities

Seroprevalence of SARS-CoV-2-specific antibodies among adults in

A cross-sectional study examining the seroprevalence of severe acute respiratory syndrome coronavirus 2 antibodies in a university student population

Seroprevalence of SARS-CoV-2 among frontline healthcare personnel in a multistate hospital network -13 academic medical centers

Severe acute respiratory syndrome coronavirus 2 seropositivity among healthcare personnel in hospitals and nursing homes

Change in antibodies to SARS-CoV-2 over 60 days among health care personnel in

We thank members of the LAC DPH COVID-19 response team who investigated outbreaks in SNFs 

All A c c e p t e d M a n u s c r i p t 26 A c c e p t e d M a n u s c r i p t